カテゴリー： 世界, 医療/バイオ, QYResearch

眼用多回投与システムの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Ophthalmic Multidose System Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10434）・商品コード：QY22JLX10434
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：90
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、眼用多回投与システムのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に眼用多回投与システムの世界市場のxxx％を占める「5ml以下」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「処方箋」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
眼用多回投与システムの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの眼用多回投与システム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

眼用多回投与システムのグローバル主要企業には、Aero Pump GmbH、Silgan Dispensing Systems、Berry Global、AptarGroup、Nemera、Ursapharm Arzneimittel GmbH、Laboratoires Thea、Gaplast GmbHなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

眼用多回投与システム市場は、種類と用途によって区分されます。世界の眼用多回投与システム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
5ml以下、5ml-10ml、10ml-30ml、その他

【用途別セグメント】
処方箋、店頭販売

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 眼用多回投与システム製品概要
- 種類別市場（5ml以下、5ml-10ml、10ml-30ml、その他）
- 用途別市場（処方箋、店頭販売）
- 調査の目的
・エグゼクティブサマリー
- 世界の眼用多回投与システム販売量予測2017-2028
- 世界の眼用多回投与システム売上予測2017-2028
- 眼用多回投与システムの地域別販売量
- 眼用多回投与システムの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別眼用多回投与システム販売量
- 主要メーカー別眼用多回投与システム売上
- 主要メーカー別眼用多回投与システム価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（5ml以下、5ml-10ml、10ml-30ml、その他）
- 眼用多回投与システムの種類別販売量
- 眼用多回投与システムの種類別売上
- 眼用多回投与システムの種類別価格
・用途別市場規模（処方箋、店頭販売）
- 眼用多回投与システムの用途別販売量
- 眼用多回投与システムの用途別売上
- 眼用多回投与システムの用途別価格
・北米市場
- 北米の眼用多回投与システム市場規模（種類別、用途別）
- 主要国別の眼用多回投与システム市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの眼用多回投与システム市場規模（種類別、用途別）
- 主要国別の眼用多回投与システム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の眼用多回投与システム市場規模（種類別、用途別）
- 主要国別の眼用多回投与システム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の眼用多回投与システム市場規模（種類別、用途別）
- 主要国別の眼用多回投与システム市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの眼用多回投与システム市場規模（種類別、用途別）
- 主要国別の眼用多回投与システム市場規模（トルコ、サウジアラビア）
・企業情報
Aero Pump GmbH、Silgan Dispensing Systems、Berry Global、AptarGroup、Nemera、Ursapharm Arzneimittel GmbH、Laboratoires Thea、Gaplast GmbH
・産業チェーン及び販売チャネル分析
- 眼用多回投与システムの産業チェーン分析
- 眼用多回投与システムの原材料
- 眼用多回投与システムの生産プロセス
- 眼用多回投与システムの販売及びマーケティング
- 眼用多回投与システムの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 眼用多回投与システムの産業動向
- 眼用多回投与システムのマーケットドライバー
- 眼用多回投与システムの課題
- 眼用多回投与システムの阻害要因
・主な調査結果

Market Analysis and Insights: Global Ophthalmic Multidose System Market
Due to the COVID-19 pandemic, the global Ophthalmic Multidose System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Less than 5 ml accounting for % of the Ophthalmic Multidose System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Prescription segment is altered to an % CAGR throughout this forecast period.
China Ophthalmic Multidose System market size is valued at US$ million in 2021, while the US and Europe Ophthalmic Multidose System are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Ophthalmic Multidose System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Ophthalmic Multidose System include Aero Pump GmbH, Silgan Dispensing Systems, Berry Global, AptarGroup, Nemera, Ursapharm Arzneimittel GmbH, Laboratoires Thea and Gaplast GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Ophthalmic Multidose System Scope and Segment
Ophthalmic Multidose System market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ophthalmic Multidose System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Less than 5 ml
5 ml-10 ml
10ml-30 ml
Other
Segment by Application
Prescription
Over-The-Counter
By Company
Aero Pump GmbH
Silgan Dispensing Systems
Berry Global
AptarGroup
Nemera
Ursapharm Arzneimittel GmbH
Laboratoires Thea
Gaplast GmbH
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Ophthalmic Multidose System Product Introduction
1.2 Market by Type
1.2.1 Global Ophthalmic Multidose System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Less than 5 ml
1.2.3 5 ml-10 ml
1.2.4 10ml-30 ml
1.2.5 Other
1.3 Market by Application
1.3.1 Global Ophthalmic Multidose System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prescription
1.3.3 Over-The-Counter
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ophthalmic Multidose System Sales Estimates and Forecasts 2017-2028
2.2 Global Ophthalmic Multidose System Revenue Estimates and Forecasts 2017-2028
2.3 Global Ophthalmic Multidose System Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ophthalmic Multidose System Sales by Region
2.4.1 Global Ophthalmic Multidose System Sales by Region (2017-2022)
2.4.2 Global Sales Ophthalmic Multidose System by Region (2023-2028)
2.5 Global Ophthalmic Multidose System Revenue by Region
2.5.1 Global Ophthalmic Multidose System Revenue by Region (2017-2022)
2.5.2 Global Ophthalmic Multidose System Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ophthalmic Multidose System Sales by Manufacturers
3.1.1 Global Top Ophthalmic Multidose System Manufacturers by Sales (2017-2022)
3.1.2 Global Ophthalmic Multidose System Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ophthalmic Multidose System in 2021
3.2 Global Ophthalmic Multidose System Revenue by Manufacturers
3.2.1 Global Ophthalmic Multidose System Revenue by Manufacturers (2017-2022)
3.2.2 Global Ophthalmic Multidose System Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ophthalmic Multidose System Revenue in 2021
3.3 Global Ophthalmic Multidose System Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ophthalmic Multidose System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ophthalmic Multidose System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ophthalmic Multidose System Sales by Type
4.1.1 Global Ophthalmic Multidose System Historical Sales by Type (2017-2022)
4.1.2 Global Ophthalmic Multidose System Forecasted Sales by Type (2023-2028)
4.1.3 Global Ophthalmic Multidose System Sales Market Share by Type (2017-2028)
4.2 Global Ophthalmic Multidose System Revenue by Type
4.2.1 Global Ophthalmic Multidose System Historical Revenue by Type (2017-2022)
4.2.2 Global Ophthalmic Multidose System Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ophthalmic Multidose System Revenue Market Share by Type (2017-2028)
4.3 Global Ophthalmic Multidose System Price by Type
4.3.1 Global Ophthalmic Multidose System Price by Type (2017-2022)
4.3.2 Global Ophthalmic Multidose System Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ophthalmic Multidose System Sales by Application
5.1.1 Global Ophthalmic Multidose System Historical Sales by Application (2017-2022)
5.1.2 Global Ophthalmic Multidose System Forecasted Sales by Application (2023-2028)
5.1.3 Global Ophthalmic Multidose System Sales Market Share by Application (2017-2028)
5.2 Global Ophthalmic Multidose System Revenue by Application
5.2.1 Global Ophthalmic Multidose System Historical Revenue by Application (2017-2022)
5.2.2 Global Ophthalmic Multidose System Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ophthalmic Multidose System Revenue Market Share by Application (2017-2028)
5.3 Global Ophthalmic Multidose System Price by Application
5.3.1 Global Ophthalmic Multidose System Price by Application (2017-2022)
5.3.2 Global Ophthalmic Multidose System Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ophthalmic Multidose System Market Size by Type
6.1.1 North America Ophthalmic Multidose System Sales by Type (2017-2028)
6.1.2 North America Ophthalmic Multidose System Revenue by Type (2017-2028)
6.2 North America Ophthalmic Multidose System Market Size by Application
6.2.1 North America Ophthalmic Multidose System Sales by Application (2017-2028)
6.2.2 North America Ophthalmic Multidose System Revenue by Application (2017-2028)
6.3 North America Ophthalmic Multidose System Market Size by Country
6.3.1 North America Ophthalmic Multidose System Sales by Country (2017-2028)
6.3.2 North America Ophthalmic Multidose System Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Ophthalmic Multidose System Market Size by Type
7.1.1 Europe Ophthalmic Multidose System Sales by Type (2017-2028)
7.1.2 Europe Ophthalmic Multidose System Revenue by Type (2017-2028)
7.2 Europe Ophthalmic Multidose System Market Size by Application
7.2.1 Europe Ophthalmic Multidose System Sales by Application (2017-2028)
7.2.2 Europe Ophthalmic Multidose System Revenue by Application (2017-2028)
7.3 Europe Ophthalmic Multidose System Market Size by Country
7.3.1 Europe Ophthalmic Multidose System Sales by Country (2017-2028)
7.3.2 Europe Ophthalmic Multidose System Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ophthalmic Multidose System Market Size by Type
8.1.1 Asia Pacific Ophthalmic Multidose System Sales by Type (2017-2028)
8.1.2 Asia Pacific Ophthalmic Multidose System Revenue by Type (2017-2028)
8.2 Asia Pacific Ophthalmic Multidose System Market Size by Application
8.2.1 Asia Pacific Ophthalmic Multidose System Sales by Application (2017-2028)
8.2.2 Asia Pacific Ophthalmic Multidose System Revenue by Application (2017-2028)
8.3 Asia Pacific Ophthalmic Multidose System Market Size by Region
8.3.1 Asia Pacific Ophthalmic Multidose System Sales by Region (2017-2028)
8.3.2 Asia Pacific Ophthalmic Multidose System Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Ophthalmic Multidose System Market Size by Type
9.1.1 Latin America Ophthalmic Multidose System Sales by Type (2017-2028)
9.1.2 Latin America Ophthalmic Multidose System Revenue by Type (2017-2028)
9.2 Latin America Ophthalmic Multidose System Market Size by Application
9.2.1 Latin America Ophthalmic Multidose System Sales by Application (2017-2028)
9.2.2 Latin America Ophthalmic Multidose System Revenue by Application (2017-2028)
9.3 Latin America Ophthalmic Multidose System Market Size by Country
9.3.1 Latin America Ophthalmic Multidose System Sales by Country (2017-2028)
9.3.2 Latin America Ophthalmic Multidose System Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Ophthalmic Multidose System Market Size by Type
10.1.1 Middle East and Africa Ophthalmic Multidose System Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ophthalmic Multidose System Revenue by Type (2017-2028)
10.2 Middle East and Africa Ophthalmic Multidose System Market Size by Application
10.2.1 Middle East and Africa Ophthalmic Multidose System Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ophthalmic Multidose System Revenue by Application (2017-2028)
10.3 Middle East and Africa Ophthalmic Multidose System Market Size by Country
10.3.1 Middle East and Africa Ophthalmic Multidose System Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ophthalmic Multidose System Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Aero Pump GmbH
11.1.1 Aero Pump GmbH Corporation Information
11.1.2 Aero Pump GmbH Overview
11.1.3 Aero Pump GmbH Ophthalmic Multidose System Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Aero Pump GmbH Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aero Pump GmbH Recent Developments
11.2 Silgan Dispensing Systems
11.2.1 Silgan Dispensing Systems Corporation Information
11.2.2 Silgan Dispensing Systems Overview
11.2.3 Silgan Dispensing Systems Ophthalmic Multidose System Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Silgan Dispensing Systems Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Silgan Dispensing Systems Recent Developments
11.3 Berry Global
11.3.1 Berry Global Corporation Information
11.3.2 Berry Global Overview
11.3.3 Berry Global Ophthalmic Multidose System Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Berry Global Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Berry Global Recent Developments
11.4 AptarGroup
11.4.1 AptarGroup Corporation Information
11.4.2 AptarGroup Overview
11.4.3 AptarGroup Ophthalmic Multidose System Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AptarGroup Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AptarGroup Recent Developments
11.5 Nemera
11.5.1 Nemera Corporation Information
11.5.2 Nemera Overview
11.5.3 Nemera Ophthalmic Multidose System Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Nemera Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nemera Recent Developments
11.6 Ursapharm Arzneimittel GmbH
11.6.1 Ursapharm Arzneimittel GmbH Corporation Information
11.6.2 Ursapharm Arzneimittel GmbH Overview
11.6.3 Ursapharm Arzneimittel GmbH Ophthalmic Multidose System Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ursapharm Arzneimittel GmbH Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ursapharm Arzneimittel GmbH Recent Developments
11.7 Laboratoires Thea
11.7.1 Laboratoires Thea Corporation Information
11.7.2 Laboratoires Thea Overview
11.7.3 Laboratoires Thea Ophthalmic Multidose System Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Laboratoires Thea Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Laboratoires Thea Recent Developments
11.8 Gaplast GmbH
11.8.1 Gaplast GmbH Corporation Information
11.8.2 Gaplast GmbH Overview
11.8.3 Gaplast GmbH Ophthalmic Multidose System Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Gaplast GmbH Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Gaplast GmbH Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ophthalmic Multidose System Industry Chain Analysis
12.2 Ophthalmic Multidose System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ophthalmic Multidose System Production Mode & Process
12.4 Ophthalmic Multidose System Sales and Marketing
12.4.1 Ophthalmic Multidose System Sales Channels
12.4.2 Ophthalmic Multidose System Distributors
12.5 Ophthalmic Multidose System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ophthalmic Multidose System Industry Trends
13.2 Ophthalmic Multidose System Market Drivers
13.3 Ophthalmic Multidose System Market Challenges
13.4 Ophthalmic Multidose System Market Restraints
14 Key Findings in The Global Ophthalmic Multidose System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Ophthalmic Multidose System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Less than 5 ml
Table 3. Major Manufacturers of 5 ml-10 ml
Table 4. Major Manufacturers of 10ml-30 ml
Table 5. Major Manufacturers of Other
Table 6. Global Ophthalmic Multidose System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Ophthalmic Multidose System Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Ophthalmic Multidose System Sales by Region (2017-2022) & (K Units)
Table 9. Global Ophthalmic Multidose System Sales Market Share by Region (2017-2022)
Table 10. Global Ophthalmic Multidose System Sales by Region (2023-2028) & (K Units)
Table 11. Global Ophthalmic Multidose System Sales Market Share by Region (2023-2028)
Table 12. Global Ophthalmic Multidose System Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Ophthalmic Multidose System Revenue Market Share by Region (2017-2022)
Table 14. Global Ophthalmic Multidose System Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Ophthalmic Multidose System Revenue Market Share by Region (2023-2028)
Table 16. Global Ophthalmic Multidose System Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Ophthalmic Multidose System Sales Share by Manufacturers (2017-2022)
Table 18. Global Ophthalmic Multidose System Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Ophthalmic Multidose System Revenue Share by Manufacturers (2017-2022)
Table 20. Ophthalmic Multidose System Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Ophthalmic Multidose System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Ophthalmic Multidose System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Multidose System as of 2021)
Table 23. Ophthalmic Multidose System Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Ophthalmic Multidose System Product Offered
Table 25. Date of Manufacturers Enter into Ophthalmic Multidose System Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Ophthalmic Multidose System Sales by Type (2017-2022) & (K Units)
Table 28. Global Ophthalmic Multidose System Sales by Type (2023-2028) & (K Units)
Table 29. Global Ophthalmic Multidose System Sales Share by Type (2017-2022)
Table 30. Global Ophthalmic Multidose System Sales Share by Type (2023-2028)
Table 31. Global Ophthalmic Multidose System Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Ophthalmic Multidose System Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Ophthalmic Multidose System Revenue Share by Type (2017-2022)
Table 34. Global Ophthalmic Multidose System Revenue Share by Type (2023-2028)
Table 35. Ophthalmic Multidose System Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Ophthalmic Multidose System Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Ophthalmic Multidose System Sales by Application (2017-2022) & (K Units)
Table 38. Global Ophthalmic Multidose System Sales by Application (2023-2028) & (K Units)
Table 39. Global Ophthalmic Multidose System Sales Share by Application (2017-2022)
Table 40. Global Ophthalmic Multidose System Sales Share by Application (2023-2028)
Table 41. Global Ophthalmic Multidose System Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Ophthalmic Multidose System Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Ophthalmic Multidose System Revenue Share by Application (2017-2022)
Table 44. Global Ophthalmic Multidose System Revenue Share by Application (2023-2028)
Table 45. Ophthalmic Multidose System Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Ophthalmic Multidose System Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Ophthalmic Multidose System Sales by Type (2017-2022) & (K Units)
Table 48. North America Ophthalmic Multidose System Sales by Type (2023-2028) & (K Units)
Table 49. North America Ophthalmic Multidose System Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Ophthalmic Multidose System Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Ophthalmic Multidose System Sales by Application (2017-2022) & (K Units)
Table 52. North America Ophthalmic Multidose System Sales by Application (2023-2028) & (K Units)
Table 53. North America Ophthalmic Multidose System Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Ophthalmic Multidose System Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Ophthalmic Multidose System Sales by Country (2017-2022) & (K Units)
Table 56. North America Ophthalmic Multidose System Sales by Country (2023-2028) & (K Units)
Table 57. North America Ophthalmic Multidose System Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Ophthalmic Multidose System Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Ophthalmic Multidose System Sales by Type (2017-2022) & (K Units)
Table 60. Europe Ophthalmic Multidose System Sales by Type (2023-2028) & (K Units)
Table 61. Europe Ophthalmic Multidose System Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Ophthalmic Multidose System Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Ophthalmic Multidose System Sales by Application (2017-2022) & (K Units)
Table 64. Europe Ophthalmic Multidose System Sales by Application (2023-2028) & (K Units)
Table 65. Europe Ophthalmic Multidose System Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Ophthalmic Multidose System Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Ophthalmic Multidose System Sales by Country (2017-2022) & (K Units)
Table 68. Europe Ophthalmic Multidose System Sales by Country (2023-2028) & (K Units)
Table 69. Europe Ophthalmic Multidose System Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Ophthalmic Multidose System Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Ophthalmic Multidose System Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Ophthalmic Multidose System Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Ophthalmic Multidose System Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Ophthalmic Multidose System Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Ophthalmic Multidose System Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Ophthalmic Multidose System Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Ophthalmic Multidose System Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Ophthalmic Multidose System Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Ophthalmic Multidose System Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Ophthalmic Multidose System Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Ophthalmic Multidose System Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Ophthalmic Multidose System Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Ophthalmic Multidose System Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Ophthalmic Multidose System Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Ophthalmic Multidose System Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Ophthalmic Multidose System Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Ophthalmic Multidose System Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Ophthalmic Multidose System Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Ophthalmic Multidose System Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Ophthalmic Multidose System Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Ophthalmic Multidose System Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Ophthalmic Multidose System Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Ophthalmic Multidose System Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Ophthalmic Multidose System Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Ophthalmic Multidose System Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Ophthalmic Multidose System Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Ophthalmic Multidose System Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Ophthalmic Multidose System Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Ophthalmic Multidose System Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Ophthalmic Multidose System Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Ophthalmic Multidose System Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Ophthalmic Multidose System Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Ophthalmic Multidose System Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Ophthalmic Multidose System Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Ophthalmic Multidose System Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Ophthalmic Multidose System Revenue by Country (2023-2028) & (US$ Million)
Table 107. Aero Pump GmbH Corporation Information
Table 108. Aero Pump GmbH Description and Major Businesses
Table 109. Aero Pump GmbH Ophthalmic Multidose System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Aero Pump GmbH Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Aero Pump GmbH Recent Developments
Table 112. Silgan Dispensing Systems Corporation Information
Table 113. Silgan Dispensing Systems Description and Major Businesses
Table 114. Silgan Dispensing Systems Ophthalmic Multidose System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Silgan Dispensing Systems Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Silgan Dispensing Systems Recent Developments
Table 117. Berry Global Corporation Information
Table 118. Berry Global Description and Major Businesses
Table 119. Berry Global Ophthalmic Multidose System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Berry Global Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Berry Global Recent Developments
Table 122. AptarGroup Corporation Information
Table 123. AptarGroup Description and Major Businesses
Table 124. AptarGroup Ophthalmic Multidose System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. AptarGroup Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. AptarGroup Recent Developments
Table 127. Nemera Corporation Information
Table 128. Nemera Description and Major Businesses
Table 129. Nemera Ophthalmic Multidose System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Nemera Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Nemera Recent Developments
Table 132. Ursapharm Arzneimittel GmbH Corporation Information
Table 133. Ursapharm Arzneimittel GmbH Description and Major Businesses
Table 134. Ursapharm Arzneimittel GmbH Ophthalmic Multidose System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Ursapharm Arzneimittel GmbH Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Ursapharm Arzneimittel GmbH Recent Developments
Table 137. Laboratoires Thea Corporation Information
Table 138. Laboratoires Thea Description and Major Businesses
Table 139. Laboratoires Thea Ophthalmic Multidose System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Laboratoires Thea Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Laboratoires Thea Recent Developments
Table 142. Gaplast GmbH Corporation Information
Table 143. Gaplast GmbH Description and Major Businesses
Table 144. Gaplast GmbH Ophthalmic Multidose System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Gaplast GmbH Ophthalmic Multidose System Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Gaplast GmbH Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Ophthalmic Multidose System Distributors List
Table 150. Ophthalmic Multidose System Customers List
Table 151. Ophthalmic Multidose System Market Trends
Table 152. Ophthalmic Multidose System Market Drivers
Table 153. Ophthalmic Multidose System Market Challenges
Table 154. Ophthalmic Multidose System Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Ophthalmic Multidose System Product Picture
Figure 3. Global Ophthalmic Multidose System Market Share by Type in 2021 & 2028
Figure 3. Less than 5 ml Product Picture
Figure 4. 5 ml-10 ml Product Picture
Figure 5. 10ml-30 ml Product Picture
Figure 6. Other Product Picture
Figure 7. Global Ophthalmic Multidose System Market Share by Application in 2021 & 2028
Figure 8. Prescription
Figure 9. Over-The-Counter
Figure 10. Ophthalmic Multidose System Report Years Considered
Figure 11. Global Ophthalmic Multidose System Sales 2017-2028 (K Units)
Figure 12. Global Ophthalmic Multidose System Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Ophthalmic Multidose System Revenue 2017-2028 (US$ Million)
Figure 14. Global Ophthalmic Multidose System Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Ophthalmic Multidose System Sales Market Share by Region (2017-2022)
Figure 16. Global Ophthalmic Multidose System Sales Market Share by Region (2023-2028)
Figure 17. North America Ophthalmic Multidose System Sales YoY (2017-2028) & (K Units)
Figure 18. North America Ophthalmic Multidose System Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Ophthalmic Multidose System Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Ophthalmic Multidose System Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Ophthalmic Multidose System Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Ophthalmic Multidose System Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Ophthalmic Multidose System Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Ophthalmic Multidose System Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Ophthalmic Multidose System Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Ophthalmic Multidose System Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Ophthalmic Multidose System Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Ophthalmic Multidose System in the World: Market Share by Ophthalmic Multidose System Revenue in 2021
Figure 29. Global Ophthalmic Multidose System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Ophthalmic Multidose System Sales Market Share by Type (2017-2028)
Figure 31. Global Ophthalmic Multidose System Revenue Market Share by Type (2017-2028)
Figure 32. Global Ophthalmic Multidose System Sales Market Share by Application (2017-2028)
Figure 33. Global Ophthalmic Multidose System Revenue Market Share by Application (2017-2028)
Figure 34. North America Ophthalmic Multidose System Sales Market Share by Type (2017-2028)
Figure 35. North America Ophthalmic Multidose System Revenue Market Share by Type (2017-2028)
Figure 36. North America Ophthalmic Multidose System Sales Market Share by Application (2017-2028)
Figure 37. North America Ophthalmic Multidose System Revenue Market Share by Application (2017-2028)
Figure 38. North America Ophthalmic Multidose System Sales Share by Country (2017-2028)
Figure 39. North America Ophthalmic Multidose System Revenue Share by Country (2017-2028)
Figure 40. United States Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Ophthalmic Multidose System Sales Market Share by Type (2017-2028)
Figure 43. Europe Ophthalmic Multidose System Revenue Market Share by Type (2017-2028)
Figure 44. Europe Ophthalmic Multidose System Sales Market Share by Application (2017-2028)
Figure 45. Europe Ophthalmic Multidose System Revenue Market Share by Application (2017-2028)
Figure 46. Europe Ophthalmic Multidose System Sales Share by Country (2017-2028)
Figure 47. Europe Ophthalmic Multidose System Revenue Share by Country (2017-2028)
Figure 48. Germany Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 49. France Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Ophthalmic Multidose System Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Ophthalmic Multidose System Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Ophthalmic Multidose System Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Ophthalmic Multidose System Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Ophthalmic Multidose System Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Ophthalmic Multidose System Revenue Share by Region (2017-2028)
Figure 59. China Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 62. India Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Ophthalmic Multidose System Sales Market Share by Type (2017-2028)
Figure 69. Latin America Ophthalmic Multidose System Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Ophthalmic Multidose System Sales Market Share by Application (2017-2028)
Figure 71. Latin America Ophthalmic Multidose System Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Ophthalmic Multidose System Sales Share by Country (2017-2028)
Figure 73. Latin America Ophthalmic Multidose System Revenue Share by Country (2017-2028)
Figure 74. Mexico Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 77. Colombia Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Ophthalmic Multidose System Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Ophthalmic Multidose System Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Ophthalmic Multidose System Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Ophthalmic Multidose System Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Ophthalmic Multidose System Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Ophthalmic Multidose System Revenue Share by Country (2017-2028)
Figure 84. Turkey Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Ophthalmic Multidose System Revenue (2017-2028) & (US$ Million)
Figure 87. Ophthalmic Multidose System Value Chain
Figure 88. Ophthalmic Multidose System Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed


★調査レポート[眼用多回投与システムの世界市場インサイト・予測（～2028年）] (コード：QY22JLX10434)販売に関する免責事項を必ずご確認ください。
★調査レポート[眼用多回投与システムの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 眼科用多回投与スポイトシステムの世界市場インサイト・予測（～2028年）
  • 眼科用スポイトシステムの世界市場インサイト・予測（～2028年）
  • 眼用粘弾性の世界市場インサイト・予測（～2028年）
  • 眼用抗ウイルス薬の世界市場インサイト・予測（～2028年）
  • 眼科用ドラッグデリバリーシステムの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆